Raymond James Financial
PJP icon

Raymond James Financial’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Raymond James Financial’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.95M Buy
47,709
+35,311
+285% +$3.73M ﹤0.01% 2597
2025
Q4 		$1.3M Buy
12,398
+2,304
+23% +$232K ﹤0.01% 3611
2025
Q3 		$934K Buy
10,094
+80
+0.8% +$7K ﹤0.01% 3729
2025
Q2 		$800K Sell
10,014
-292
-3% -$23.3K ﹤0.01% 3715
2025
Q1 		$893K Sell
10,306
-1,109
-10% -$94.5K ﹤0.01% 3577
2024
Q4 		$943K Buy
+11,415
New +$982K ﹤0.01% 3489

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Raymond James Financial's PJP Position: Q1 2026 in Review

Raymond James Financial increased its Invesco Pharmaceuticals ETF (PJP) stake by 285% in Q1 2026, buying an estimated $3.73M and bringing the position to 47,709 shares worth $4.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2597.

Raymond James Financial first reported a position in PJP in Q4 2024 and has held it in 6 quarters since. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Raymond James Financial held 47,709 shares of Invesco Pharmaceuticals ETF worth $4.95M as of Q1 2026.
  • Raymond James Financial bought 35,311 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $3.73M.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2597 holding.
  • Raymond James Financial first reported a position in Invesco Pharmaceuticals ETF in Q4 2024 and has held it in 6 quarters since.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.